关键词：亚太地区；生物科技；环境；市场展望与趋势
摘 要：The Asia-Pacific biotech industry remained one of the fastest emerging knowledge-based industries in the region over the last six months. Several leading companies reported higher revenues, while an average of the stock prices of companies tracked by Mergent rose 4.07% over the six-month period. Due to economic challenges in several major markets, a steady number of foreign biotech and pharmaceutical companies, particularly from North America and Europe, shifted their focus to markets in the Asia-Pacific. The industry also saw several cross-border mergers and acquisitions (M&A) as biotech companies sought to obtain the benefits of various fiscal incentives in other nations and regions.